Pharmacy Chain 36.6 Income Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	87,163	67,358	59,048	44,104	39,267
Revenue Growth (YoY)	29.40%	14.07%	33.88%	12.32%	7.51%
Cost of Revenue	59,027	45,319	39,049	29,147	25,860
Gross Profit	28,136	22,039	19,999	14,957	13,407
Selling, General & Admin	21,658	17,825	15,931	14,235	12,584
Other Operating Expenses	-286	-298	-444	-456	-571
Operating Expenses	21,402	17,586	15,681	13,997	12,160
Operating Income	6,734	4,453	4,318	960	1,247
Interest Expense	-6,578	-4,140	-4,241	-3,239	-4,634
Interest & Investment Income	346	283	391	412	83
Currency Exchange Gain (Loss)	9	-45	14	30	-202
Other Non Operating Income (Expenses)	-324	-251	-251	-212	-181
EBT Excluding Unusual Items	187	300	231	-2,049	-3,687
Gain (Loss) on Sale of Assets	-190	-28	107	-2	36
Asset Writedown	212	-110	73	609	3,008
Pretax Income	209	162	411	-1,442	-643
Income Tax Expense	-58	42	188	-492	349
Earnings From Continuing Operations	267	120	223	-950	-992
Earnings From Discontinued Operations	-	-	-	-	7,343
Net Income to Company	267	120	223	-950	6,351
Net Income	267	120	223	-950	6,351
Net Income to Common	267	120	223	-950	6,351
Net Income Growth	122.50%	-46.19%	-	-	-
Shares Outstanding (Basic)	7,576	7,617	7,630	7,630	6,807
Shares Outstanding (Diluted)	7,576	7,617	7,630	7,630	6,807
Shares Change (YoY)	-0.54%	-0.17%	-	12.11%	39.36%
EPS (Basic)	0.04	0.02	0.03	-0.12	0.93
EPS (Diluted)	0.04	0.02	0.03	-0.12	0.93
EPS Growth	123.72%	-46.10%	-	-	-
Free Cash Flow	5,771	6,399	5,901	2,528	-5,058
Free Cash Flow Per Share	0.76	0.84	0.77	0.33	-0.74
Gross Margin	32.28%	32.72%	33.87%	33.91%	34.14%
Operating Margin	7.73%	6.61%	7.31%	2.18%	3.18%
Profit Margin	0.31%	0.18%	0.38%	-2.15%	16.17%
Free Cash Flow Margin	6.62%	9.50%	9.99%	5.73%	-12.88%
EBITDA	8,158	5,848	5,724	2,130	2,264
EBITDA Margin	9.36%	8.68%	9.69%	4.83%	5.77%
D&A For EBITDA	1,424	1,395	1,406	1,170	1,017
EBIT	6,734	4,453	4,318	960	1,247
EBIT Margin	7.73%	6.61%	7.31%	2.18%	3.18%
Effective Tax Rate	-	25.93%	45.74%	-	-
Advertising Expenses	441	543	368	213	166

Source: S&P Global Market Intelligence. Standard template. Financial Sources.